Hudsonalpha Institute of Biotechnology
Nonprofit Biotechnology Research Organization
Based in AL
🤖
AI Overview
With $440K in lobbying spend across 17 quarterly filings, Hudsonalpha Institute of Biotechnology is an active lobbying client. Their lobbying covers 4 issue areas. Active from 2021 to 2025.
$440K
Total Spend
5
Years Active
1
Firms Hired
4
Lobbyists Deployed
4
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2021 | $50K |
| 2022 | $120K |
| 2023 | $120K |
| 2024 | $120K |
| 2025 | $30K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Budget/Appropriations, Agriculture, Health Issues, Computer Industry
- •Monitor FY22 Agriculture, Rural Development, Food and Drug Administration Appropriations bills. Monitor developments around the Farm Bill. Monitor legislation as it relates to healthcare. Monitor Lab
- •Monitor legislation as it relates to healthcare, Monitor Labor/HHS/Education fiscal year Appropriations bill. Monitor fiscal year Agriculture, Rural Development, Food and Drug Administration Appropria
- •Monitor fiscal year Agriculture, Rural Development, Food and Drug Administration appropriations bills. Monitor developments around the Farm Bill
Related Analysis
Related Investigations
The 22,000% ROI
When lobbying spending yields outsized returns.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
The Crypto Lobbying Explosion
How crypto went from zero to massive lobbying presence.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.